Anticancer drug Gefitinib encapsulated within human heavy chain apoferritin by diffusion allows pH-controlled sustained release of cargo. The combination of increased cellular uptake, and potent and enhanced antitumor activity against the HER2 overexpressing SKBR3 cell line compared to Gefitinib alone, makes it a promising carrier for delivery of drugs to tumor sites.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/adhm.201500389 | DOI Listing |
Publication Analysis
Top Keywords
apoferritin-based drug
4
drug delivery
4
delivery system
4
system tyrosine
4
tyrosine kinase
4
kinase inhibitor
4
inhibitor gefitinib
4
gefitinib anticancer
4
anticancer drug
4
drug gefitinib
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!